IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 220 life science manufacturers of all size and complexity rely on IntegriChain’s analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data. IntegriChain has played a vital role in more than 70% of product launches over the past two years including 35 first launches.

On February 1, 2019, Zitter Health Insights joined MMIT. One of two reps retained during the merger.As one company, MMIT provides robust access solutions, including unparalleled depth and breadth of information for the pharma industry across the lifecycle of a brand. by providing insight into: • Payer management of pharmacy and medical benefit drugs, including prior authorization polices and formulary access• Market Access teams’ messaging to payers• Simulated P&T perspective meetings• Syndicated Primary Market Research focused on Oncology and Specialty drugs

Helping Specialty Pharmacies and Pharmaceutical Manufacturers:1. Patient Satisfaction Survey (PSS) – syndicated benchmarking service on patients and their satisfaction with specialty pharmacy. The services provides objective, comparative assessments of all major specialty pharmacies.2. Physician Satisfaction Survey (MDSS) – sister service similar to the Patient Satisfaction Survey (PSS), but focused on providers. 3. Patient Reimbursement Database (PRDB) – comprehensive database of more than 500 support programs that provide financial support to patients. It tracks co-pay offset programs, patient assistance programs, and foundational assistance programs spanning over 120 specialty therapeutic areas / tumor types.